Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$117.91
-7.64-6.08%
At close: Dec 15, 4:00 PM EST
$116.02
-1.89-1.60%
After Hours: 7:56 PM EST
Comments
Loading...
Abivax Analyst Ratings and Price Targets | NASDAQ:ABVX | Benzinga
Abivax SA has a consensus price target of $91.94 based on the ratings of 16 analysts. The high is $176 issued by Wolfe Research on November 6, 2025. The low is $16 issued by Morgan Stanley on April 11, 2024. The 3 most-recent analyst ratings were released by Truist Securities, Wolfe Research, and Barclays on November 24, 2025, November 6, 2025, and October 13, 2025, respectively. With an average price target of $152.67 between Truist Securities, Wolfe Research, and Barclays, there's an implied 31.59% upside for Abivax SA from these most-recent analyst ratings.
Analyst Firms Making Recommendations1
Truist Securities
Wolfe Research
Barclays
Guggenheim
BTIG
1calculated from analyst ratings
Analyst Ratings for Abivax
FAQ
What is the target price for Abivax (ABVX) stock?
The latest price target for Abivax (NASDAQ:ABVX) was reported by Truist Securities on November 24, 2025. The analyst firm set a price target for $140.00 expecting ABVX to rise to within 12 months (a possible 20.67% upside). 18 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Abivax (ABVX)?
The latest analyst rating for Abivax (NASDAQ:ABVX) was provided by Truist Securities, and Abivax initiated their buy rating.
When was the last upgrade for Abivax (ABVX)?
The last upgrade for Abivax SA happened on July 23, 2025 when Morgan Stanley raised their price target to $71. Morgan Stanley previously had an equal-weight for Abivax SA.
When was the last downgrade for Abivax (ABVX)?
There is no last downgrade for Abivax.
When is the next analyst rating going to be posted or updated for Abivax (ABVX)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Abivax, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Abivax was filed on November 24, 2025 so you should expect the next rating to be made available sometime around November 24, 2026.
Is the Analyst Rating Abivax (ABVX) correct?
While ratings are subjective and will change, the latest Abivax (ABVX) rating was a initiated with a price target of $0.00 to $140.00. The current price Abivax (ABVX) is trading at is $116.02, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.
